UP Govt Approves 2% DA Hike for State Employees from January 2025

The Uttar Pradesh government has announced a 2% hike in Dearness Allowance (DA) for its state employees. The allowance has been revised from 53% to 55% of the basic pay. This change will come into effect from January 1, 2025, and will be reflected in the April 2025 salary, which will be disbursed in May 2025.

Impact on Employees and Pensioners

As per the news reports, the DA hike will benefit around 16 lakh state government employees. In addition, approximately 12 lakh pensioners will receive a 2% increase in Dearness Relief (DR). The announcement was made by Chief Minister Yogi Adityanath through social media.

“Today, it has been decided by the Uttar Pradesh Government to increase the Dearness Allowance being given to the State employees at the rate of 53% to 55% from 01.01.2025. Around 16 lakh employees will benefit from this decision,” he posted in Hindi. “Hearty congratulations to all of you!” he added.

According to an official spokesperson, the hike, approved by Chief Minister Yogi Adityanath, will place an additional monthly burden of ₹107 crore on the state treasury. The state government will disburse ₹193 crore as arrears in salaries and deposit ₹129 crore in the GPF accounts of employees under the old pension scheme.

Central Government’s DA/DR Revision

Before this, the Union Cabinet had approved a similar 2% hike in DA and DR for central government employees and pensioners, also effective from January 1, 2025. This revision increases the rate from 53% to 55%, impacting 48.66 lakh employees and 66.55 lakh pensioners. The combined annual financial implication for the central government is estimated at ₹6,614.04 crore.

The DA and DR revisions are calculated based on the 12-month average of the All India Consumer Price Index for Industrial Workers (AICPI-IW) released by the Labour Bureau.

Other States: Assam and Maharashtra

On April 4, 2025, Assam Chief Minister Himanta Biswa Sarma announced a 2% hike in DA for state employees and pensioners. The increase will also be effective from January 1, 2025, with the revised amount to be added before Bihu. Arrears will be cleared in April and May.

In March 2024, the Maharashtra government announced a 12% DA hike under the 5th Pay Commission’s unrevised pay scale. The hike, from 443% to 455%, took effect from July 1, 2024, and is being disbursed with the February 2025 salary, including arrears from July 2024 to January 2025. Around 17 lakh employees were covered under this revision.

Conclusion

The 2% increase in DA in Uttar Pradesh aligns with similar revisions across other states and the Centre. The hike will apply from January 2025 and is set to benefit both current employees and pensioners.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Coromandel International Secures Long-Term Fertiliser Supply Deal with Saudi Arabia’s Ma’aden

Coromandel International Ltd has signed a Memorandum of Understanding (MoU) with Saudi Arabia’s Ma’aden for the long-term supply of Di-Ammonium Phosphate (DAP) and NP/NPK fertilisers. As per the reports, the agreement was signed on April 9 and builds on a long-standing relationship between the two companies.

As of 9:39 AM on April 11, 2025, Coromandel International share price was trading at ₹2080, a 3.76% up, it has gained 23.31% over the past six months and 74.94% over the past year.

Background

Ma’aden has been supplying ammonia to Coromandel for several years. It has also been India’s largest supplier of phosphate fertilisers for over a decade. The new MoU is to support the regular availability of fertilisers in India, which has recently seen supply disruptions.

Ma’aden’s Expansion 

To meet growing demand, Ma’aden is increasing its phosphate fertiliser production from 6 million tonnes to 9 million tonnes. In 2024, the company reported revenue of SAR 39.88 billion (approximately USD 10.72 billion).

Coromandel’s Reach

Coromandel is the second-largest manufacturer and marketer of phosphatic fertilisers in India. It operates in two segments: nutrients and crop protection. The company runs 18 manufacturing facilities and over 900 retail outlets across Andhra Pradesh, Telangana, Karnataka, and Tamil Nadu. Through these outlets, it serves more than 4.5 million farmers.

In Q3 FY25, Coromandel’s consolidated net profit rose 121.6% year-on-year to ₹511.77 crore. Net sales stood at ₹6,935.19 crore, up 26.9% from the previous year.

Conclusion

The agreement secures a long-term fertiliser supply to India and signals continued cooperation between the two companies in different areas, including raw material sourcing and agricultural input support.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Waaree Renewable Technologies Commences Trading on NSE with Growth in Focus

Waaree Renewable Technologies Ltd (WRTL), a solar EPC (engineering, procurement and construction) company, has been listed on the National Stock Exchange (NSE) as of April 10. The company is now trading under the symbol WRTL.

As of 9:44 AM on April 11, 2025, Waaree Renewable Technologies share price was trading at ₹883.85, a 3.17% up. The listing gives WRTL public market access, expanding its investor base and visibility.

Completed and Ongoing Projects

WRTL has completed over 1.82 gigawatts (GW) of solar EPC installations so far. In addition, the company is currently executing another 1.7 GW worth of solar projects. These include large-scale solar plants across multiple regions.

Future Pipeline

WRTL has a bidding pipeline of 17.8 gigawatt-peak (GWp), which consists of upcoming projects the company is pursuing through tenders. The pipeline showcases both the scale of opportunity in the solar EPC space and the company’s growth ambitions.

Focus on Data Centres

Apart from utility-scale solar projects, the company is also providing solar energy solutions for data centres. As demand for digital infrastructure grows, the energy requirements for such centres are increasing, creating new opportunities for solar providers.

Company’s Statement

In an official statement, the company referred to the NSE debut as a key milestone in its journey. Director Viren C Doshi said that the listing symbolises credibility, scale, and intent. The company also noted that the listing would help improve access to capital and support future growth.

About WRTL

Waaree Renewable Technologies is involved in end-to-end solar project execution. Its services include planning, procurement, and construction for solar infrastructure projects.

Conclusion

The NSE listing comes at a time when WRTL is expanding its project base. With completed projects, ongoing work, and a large bidding pipeline, the company remains active in India’s renewable energy sector.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

CBDT Sets April 30 Deadline for Vivad Se Vishwas Tax Arrears Declarations

The Central Board of Direct Taxes (CBDT) has announced April 30, 2025, as the final date for taxpayers to file declarations under the Direct Tax Vivad se Vishwas Scheme, 2024.

About the Scheme

The Vivad se Vishwas (VSV) Scheme 2024 was introduced as part of Budget 2024 and became operational on October 1, 2024. It is meant to resolve direct tax disputes by allowing taxpayers to settle outstanding cases with the Income Tax Department. This is the second version of the scheme, following the first edition in 2020.

Who Is Eligible?

Only disputes that were pending as on July 22, 2024, are covered under the scheme. Taxpayers can apply even if their appeal has since been disposed of, as long as it was pending on the specified date.

Appeals before the following authorities are eligible:

  • Commissioner of Income Tax (Appeals)1
  • Income Tax Appellate Tribunal (ITAT)
  • High Courts
  • Supreme Court

However, the scheme cannot be used if:

  • The matter is pending before the Income Tax Settlement Commission
  • A review petition is pending before a High Court or the Supreme Court

Filing Process and Form

Taxpayers must file a declaration in Form 1 and submit it to the designated authority by April 30, 2025. The declaration must be made under Section 90 of the Finance (No. 2) Act, 2024.

As per the news reports, the Income Tax Department shared the update on its official X (formerly Twitter) handle. A set of FAQs explaining the scheme has also been uploaded to the department’s portal.

The CBDT has confirmed that this is the first time a deadline has been formally notified for filing declarations under the 2024 scheme.

Conclusion

The window to file under the Vivad se Vishwas Scheme 2024 will close on April 30, 2025. Taxpayers with eligible disputes are required to complete and submit the necessary documentation within this timeframe.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

HSBC and Franklin Templeton Mutual Funds Restrict Fresh Investments on These Funds

Starting April 9, 2025, HSBC Mutual Fund and Franklin Templeton Mutual Fund have announced restrictions on fresh inflows in specific debt-oriented schemes. The restrictions apply to new investments, switches, and registration of systematic plans.

HSBC Mutual Fund: Two Schemes Affected

HSBC Mutual Fund has restricted fresh subscriptions in the following schemes:

The restrictions cover all types of new inflows, including:

  • Lumpsum investments
  • Switch-ins from other schemes
  • New registrations of Systematic Investment Plans (SIPs)
  • New registrations of Systematic Transfer Plans (STPs)

The restriction will be effective from April 9, 2025, and will remain in place until further notice. Existing SIPs and STPs already registered before the cut-off date will continue as scheduled. Redemptions are not impacted by this restriction.

Franklin Templeton Mutual Fund: Corporate Debt Fund Suspended

Franklin Templeton Mutual Fund has suspended new subscriptions in the Franklin India Corporate Debt Fund, also effective April 9, 2025. The suspension includes:

  • Lumpsum investments
  • Switch-ins
  • New SIP registrations
  • New STP registrations

This restriction, like HSBC’s, will continue until further notice. Existing investment instructions set up prior to the effective date will continue without disruption.

Applicable Across All Platforms

The restrictions by both fund houses are applicable across all distribution platforms and channels. Investors will not be able to initiate any new inflow transactions into the mentioned schemes after the effective date.

Conclusion

From April 9, 2025, new investments and systematic plan registrations into HSBC’s Credit Risk and Low Duration Funds, as well as Franklin Templeton’s India Corporate Debt Fund, will not be accepted. These restrictions will continue until further updates are provided by the respective fund houses.

Plan your SBI SIP investments better! Use our easy-to-use SBI SIP Calculator and estimate future returns with just a few clicks. Your financial growth starts here.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Mutual Fund investments in the securities market are subject to market risks, read all the related documents carefully before investing.

NTPC Green Energy and MAHAPREIT Join Hands for 10 GW Renewable Energy Project

NTPC Green Energy Limited (NGEL), a subsidiary of NTPC Limited, has officially announced the incorporation of a new joint venture company named NTPC-MAHAPREIT Green Energy Limited to develop a massive 10 GW Renewable Energy Parks. This entity, incorporated on 8th April 2025, marks a strategic partnership between NGEL and Mahatma Phule Renewable Energy and Infrastructure Technology Limited (MAHAPREIT). NGEL holds a 74% stake, while MAHAPREIT holds the remaining 26%. The primary objective of this venture is to focus on the development, operation, and maintenance of renewable energy parks and projects across India, especially in Maharashtra.

This initiative is a noteworthy development in India’s clean energy landscape, symbolising collaboration between major public sector undertakings to scale green infrastructure. The incorporation received requisite approvals from key governmental bodies, including the Ministry of Power, DIPAM, and NITI Aayog.

Second Phase of Dayapar Wind Energy Project Commissioned

NTPC Renewable Energy Limited, a fully owned subsidiary of NTPC Green Energy Limited (NGEL), has formally declared the commercial operation of the second phase of its 150 MW Dayapar Wind Energy Project. With this, an additional capacity of 90 MW has been successfully commissioned and became operational from 00:00 hours on 9th April 2025. The project is part of a larger 450 MW Hybrid Project located in Dayapar, Bhuj, Gujarat.

This milestone follows the earlier commissioning of the first 50 MW segment, which was declared commercially operational on 4th November 2023. The achievement highlights NTPC’s ongoing commitment to expanding India’s renewable energy portfolio and strengthening its sustainable power infrastructure.

A Major Boost to India’s Hybrid Energy Infrastructure

The Dayapar Wind Energy Project is a key component of NTPC’s broader strategy to integrate diverse renewable energy sources, particularly under hybrid project structures. The 450 MW Hybrid Project combines both solar and wind resources to ensure efficient and reliable power generation.

By commissioning this second phase of wind capacity, NTPC Green Energy Limited enhances the total operational capacity under the hybrid model, optimising grid stability and contributing towards national renewable energy targets. The successful rollout also reflects the organisation’s technical capabilities and focus on timely execution.

NTPC Green Share Performance 

As of April 09, 2025, at 2:30 PM, NTPC Green share price is trading at ₹95.49 per share, reflecting a decline of 0.96% from the previous day’s closing price

Conclusion

The commercial launch of the 90 MW wind capacity marks a significant achievement for NTPC Renewable Energy Limited and reinforces NTPC Green Energy’s role in India’s transition to sustainable energy. With the full 150 MW now operational at Dayapar, the company continues to play a vital role in driving hybrid renewable solutions across the country.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Concord Biotech Secures USFDA Approval for Teriflunomide Tablets to Treat Multiple Sclerosis

Concord Biotech Limited, a pharmaceutical company headquartered in Gujarat, India, has achieved a significant milestone with its latest announcement. On April 8, 2025, the company disclosed that it has secured final approval from the United States Food and Drug Administration (USFDA) to market Teriflunomide tablets in 7 mg and 14 mg dosages. This approval marks a pivotal step in the company’s journey towards expanding its presence in international markets, particularly in the high-value pharmaceutical segment of the United States.

The approved drug, Teriflunomide, is used in the treatment of relapsing forms of multiple sclerosis (MS), a chronic illness that affects the central nervous system. The development of this product underscores Concord Biotech’s growing capabilities in formulating and delivering differentiated therapeutic solutions on a global scale.

Strategic Relevance of the Approval 

Securing USFDA approval is widely regarded as a hallmark of pharmaceutical excellence and regulatory compliance. For Concord Biotech, this approval is more than just an entry into a new market—it is a testament to the company’s research and development strength. The U.S. market, being one of the largest and most regulated in the world, opens up considerable commercial opportunities for the company.

According to data from IQVIA™, the U.S. market for Teriflunomide tablets stands at approximately $402 million, while the global market is valued at around $908 million. By entering this segment, Concord not only strengthens its international footprint but also positions itself as a competitive player in the neurological disorders segment, a space increasingly characterised by innovation and high demand.

Expanding Global Outlook

The approval aligns with Concord Biotech’s long-term strategy of diversifying its product offerings and entering regulated markets with high growth potential. The company has consistently focused on differentiated products that can address unmet medical needs. By obtaining clearance to commercialise Teriflunomide in the U.S., Concord is demonstrating its commitment to expanding its reach and making critical therapies accessible across borders.

 

Moreover, the commercialisation of Teriflunomide tablets adds to Concord’s growing portfolio of approved products, bolstering its reputation as a reliable supplier of niche and essential pharmaceuticals. This achievement not only strengthens the company’s credibility among global stakeholders but also enhances its ability to contribute meaningfully to the treatment of neurological conditions worldwide.

Concord BioTech Share Performance 

As of April 09, 2025, at 2:30 PM, Concord Biotech share price is trading at 1,607.95 per share, reflecting a surge of over 0.71% from the previous day’s closing price.

Conclusion

Concord Biotech’s latest regulatory milestone represents a strategic victory in its ongoing mission to deliver cutting-edge therapies to global markets. The USFDA’s approval of Teriflunomide tablets highlights the company’s robust R&D efforts and its potential to tap into substantial market opportunities in both the United States and worldwide. With a strong pipeline and clear global ambitions, Concord is well-positioned to make a lasting impact in the pharmaceutical sector.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing

 

GAIL Establishes Finance Subsidiary in GIFT City for Global Operations

In a strategic move to broaden its financial operations, GAIL (India) Limited has incorporated a wholly owned subsidiary—GAIL Global IFSC Limited—within the International Financial Services Centre (IFSC) at Gujarat International Finance Tec-City (GIFT City), Gujarat. This development aligns with the company’s vision to enhance its global presence and capital management capabilities through structured financial channels within India’s premier financial hub.

Incorporation Details and Regulatory Approvals

GAIL Global IFSC Limited was formally established on 7th April 2025 with an authorised share capital of ₹17 crore and an initial paid-up capital of ₹8.5 crore. The Ministry of Petroleum & Natural Gas, Government of India, approved the formation of this subsidiary with confirmation from the Department of Investment and Public Asset Management (DIPAM) as of 13th March 2025.

This new entity will function as a finance company within the IFSC, adhering to all guidelines of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The entire investment has been made via cash consideration, with GAIL acquiring 100% of the equity at ₹10 per share.

Objectives and Strategic Intent

The primary goal of GAIL Global IFSC Limited is to engage in Global or Regional Corporate Treasury Centre activities and ship leasing operations, both strategically significant but distinct from GAIL’s conventional line of business in natural gas. This move allows GAIL to diversify its functional reach into the realm of international finance while retaining complete control and ownership over its new venture.

Although the subsidiary currently does not report any turnover or operational history, its establishment within the IFSC marks a calculated step towards international integration and financial efficiency for the parent company.

GAIL Share Performance 

As of April 09, 2025, at 2:30 PM, GAIL share price is trading at ₹166.70 per share, reflecting a decline of over 2% from the previous day’s closing price.

Conclusion

The formation of GAIL Global IFSC Limited signifies a pivotal expansion of GAIL’s corporate landscape. By stepping into the financial services space through the GIFT City IFSC, GAIL aims to capitalise on global financial flows and fortify its treasury capabilities, thereby marking a notable milestone in its strategic evolution.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

 

Sasken Technologies Acquires 100% Stake in BORQS International to Expand Global IoT Footprint

On 8th April 2025, Sasken Technologies Limited announced the successful completion of its 100% acquisition of BORQS International Holding Corp and its wholly owned subsidiaries. The transaction was executed through Sasken Design Solutions Pte. Ltd, a wholly owned subsidiary based in Singapore. With this strategic acquisition, Sasken aims to enhance its offerings in the field of connected devices and Internet of Things (IoT) solutions.

Acquisition to Strengthen End-to-End IoT Capabilities

BORQS International specialises in the design, development, and management of customised IoT devices and solutions. The acquisition supports Sasken’s ambition to provide a full-stack service — from ideation and intellectual property development to software implementation, product realisation, and hardware supply chain management. This move positions Sasken as a more comprehensive solution provider in the IoT space, catering to a global clientele.

The share purchase agreement was signed on 8th April 2025 for a total consideration not exceeding $40 million (approximately ₹338 crore), subject to adjustments and completion of specific conditions. This acquisition does not involve any related party transactions and was carried out entirely in cash.

Global Expansion with Strategic Presence Across Key Markets

Established in 2007, BORQS International has a presence in India, Hong Kong, and the People’s Republic of China. Over the past three years, its turnover has ranged between $29 million and $52 million. With this acquisition, the BORQS entities have become step-down subsidiaries of Sasken, adding to its global operational footprint and expanding its market reach.

 

Sasken intends to leverage BORQS’s capabilities to better support its clients with integrated solutions and accelerate the commercialisation of next-generation connected products. The acquisition does not require any governmental or regulatory approvals.

Sasken Technologies Share Performance 

As of April 09, 2025, at 2:30 PM, Sasken Technologies share price is trading at ₹1,303.35 per share, reflecting a decline of over 2% from the previous day’s closing price.

Conclusion

The acquisition of BORQS International by Sasken Technologies marks a pivotal step in its growth strategy, aimed at reinforcing its position in the IoT ecosystem. With enhanced technical capabilities and a broader geographic presence, Sasken is now poised to offer deeper value to its customers in the fast-evolving digital landscape.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

SEBI Tightens Investor Protection Norms with ‘1600’ Number Series Mandate

In a significant move to bolster investor protection and reduce instances of financial fraud, the Securities and Exchange Board of India (SEBI) has issued a new directive. All regulated and registered entities are now required to use phone numbers starting with the ‘1600’ series exclusively for service and transactional voice calls to existing customers.

Streamlining Caller Identification for Investors

The regulator’s decision is aimed at making it easier for investors to distinguish legitimate communication from potential scam calls. Typically, fraudsters disguise themselves using standard 10-digit mobile numbers, misleading investors into engaging in fraudulent transactions. The adoption of the ‘1600’ series will enable investors to quickly identify calls from genuine SEBI-regulated entities, significantly reducing the chances of deception.

Steps for Reporting Unsolicited or Fraudulent Communication

To further strengthen the security net, SEBI has urged investors to remain alert and report any Unsolicited Commercial Communications (UCC). Such reports can be submitted through the DND facility offered by telecom providers such as Airtel, Jio, Vi, MTNL, and BSNL. Alternatively, users can lodge complaints using the TRAI DND app or by contacting 1909. In more serious cases of suspected fraud, investors are advised to report such instances to the Department of Telecommunications via the Chakshu Platform. If a financial fraud has already taken place, victims can contact the Cyber Crime Helpline at 1930 or file a report through www.cybercrime.gov.in.

Conclusion

SEBI’s introduction of the ‘1600’ number series for all service-related calls represents a proactive step toward ensuring a safer investment environment. By simplifying the identification of legitimate communication, the regulator hopes to curb fraudulent activity and reinforce trust in the financial system.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.